Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.04886407 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.04886407 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.73663533 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.73663533 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.28582217 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.86346508 |
7 | tryptophan catabolic process (GO:0006569) | 5.66726857 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.66726857 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.66726857 |
10 | kynurenine metabolic process (GO:0070189) | 5.58838808 |
11 | glyoxylate metabolic process (GO:0046487) | 5.54776050 |
12 | bile acid biosynthetic process (GO:0006699) | 5.49154377 |
13 | * alpha-linolenic acid metabolic process (GO:0036109) | 5.41780423 |
14 | tryptophan metabolic process (GO:0006568) | 5.33551180 |
15 | epoxygenase P450 pathway (GO:0019373) | 5.32991079 |
16 | cysteine metabolic process (GO:0006534) | 5.19692327 |
17 | urea metabolic process (GO:0019627) | 5.13698188 |
18 | urea cycle (GO:0000050) | 5.13698188 |
19 | sulfur amino acid catabolic process (GO:0000098) | 5.10435074 |
20 | lysine metabolic process (GO:0006553) | 4.94519604 |
21 | lysine catabolic process (GO:0006554) | 4.94519604 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.88846494 |
23 | negative regulation of fibrinolysis (GO:0051918) | 4.81902660 |
24 | complement activation, alternative pathway (GO:0006957) | 4.81226411 |
25 | serine family amino acid catabolic process (GO:0009071) | 4.74495594 |
26 | bile acid metabolic process (GO:0008206) | 4.73794300 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.73728946 |
28 | protein carboxylation (GO:0018214) | 4.73728946 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.73052659 |
30 | regulation of protein activation cascade (GO:2000257) | 4.71919362 |
31 | regulation of triglyceride catabolic process (GO:0010896) | 4.68465786 |
32 | * fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65275081 |
33 | amino-acid betaine metabolic process (GO:0006577) | 4.63612382 |
34 | homocysteine metabolic process (GO:0050667) | 4.63057424 |
35 | regulation of fibrinolysis (GO:0051917) | 4.62718593 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 4.54957812 |
37 | cellular ketone body metabolic process (GO:0046950) | 4.52132956 |
38 | alpha-amino acid catabolic process (GO:1901606) | 4.42930199 |
39 | tyrosine metabolic process (GO:0006570) | 4.40800993 |
40 | regulation of complement activation (GO:0030449) | 4.40492341 |
41 | triglyceride homeostasis (GO:0070328) | 4.38646156 |
42 | acylglycerol homeostasis (GO:0055090) | 4.38646156 |
43 | reverse cholesterol transport (GO:0043691) | 4.37566475 |
44 | regulation of cholesterol esterification (GO:0010872) | 4.34044714 |
45 | macromolecular complex remodeling (GO:0034367) | 4.30296891 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.30296891 |
47 | protein-lipid complex remodeling (GO:0034368) | 4.30296891 |
48 | glutamate metabolic process (GO:0006536) | 4.20153068 |
49 | negative regulation of sterol transport (GO:0032372) | 4.19709525 |
50 | negative regulation of cholesterol transport (GO:0032375) | 4.19709525 |
51 | coenzyme catabolic process (GO:0009109) | 4.16537693 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 4.15148045 |
53 | cellular amino acid catabolic process (GO:0009063) | 4.14699995 |
54 | phospholipid efflux (GO:0033700) | 4.14312409 |
55 | drug catabolic process (GO:0042737) | 4.06108492 |
56 | ethanol oxidation (GO:0006069) | 4.04254329 |
57 | cellular modified amino acid catabolic process (GO:0042219) | 4.02895575 |
58 | acetyl-CoA metabolic process (GO:0006084) | 4.01062793 |
59 | intestinal absorption (GO:0050892) | 4.00738919 |
60 | bile acid and bile salt transport (GO:0015721) | 4.00695492 |
61 | short-chain fatty acid metabolic process (GO:0046459) | 4.00444953 |
62 | omega-hydroxylase P450 pathway (GO:0097267) | 4.00375063 |
63 | indolalkylamine metabolic process (GO:0006586) | 4.00145011 |
64 | cellular glucuronidation (GO:0052695) | 3.93525545 |
65 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93423043 |
66 | ketone body metabolic process (GO:1902224) | 3.91788225 |
67 | benzene-containing compound metabolic process (GO:0042537) | 3.86741578 |
68 | cellular biogenic amine catabolic process (GO:0042402) | 3.86064900 |
69 | amine catabolic process (GO:0009310) | 3.86064900 |
70 | serine family amino acid metabolic process (GO:0009069) | 3.85261024 |
71 | cholesterol efflux (GO:0033344) | 3.83558517 |
72 | positive regulation of lipid catabolic process (GO:0050996) | 3.82405628 |
73 | glycine metabolic process (GO:0006544) | 3.78843370 |
74 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.77997385 |
75 | * fatty acid beta-oxidation (GO:0006635) | 3.77448361 |
76 | drug transmembrane transport (GO:0006855) | 3.77267543 |
77 | angiotensin maturation (GO:0002003) | 3.77049840 |
78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74560212 |
79 | * carboxylic acid catabolic process (GO:0046395) | 3.73984025 |
80 | * organic acid catabolic process (GO:0016054) | 3.73984025 |
81 | phospholipid homeostasis (GO:0055091) | 3.73533061 |
82 | * fatty acid oxidation (GO:0019395) | 3.72416674 |
83 | imidazole-containing compound metabolic process (GO:0052803) | 3.72108260 |
84 | lipoprotein transport (GO:0042953) | 3.71427147 |
85 | aspartate family amino acid catabolic process (GO:0009068) | 3.68400609 |
86 | drug metabolic process (GO:0017144) | 3.68088302 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 3.67751998 |
88 | flavonoid metabolic process (GO:0009812) | 3.67557005 |
89 | * lipid oxidation (GO:0034440) | 3.65788390 |
90 | * monocarboxylic acid catabolic process (GO:0072329) | 3.64540311 |
91 | arginine metabolic process (GO:0006525) | 3.62450395 |
92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62003213 |
93 | * fatty acid catabolic process (GO:0009062) | 3.60172197 |
94 | urate metabolic process (GO:0046415) | 3.59801184 |
95 | negative regulation of protein activation cascade (GO:2000258) | 3.58366253 |
96 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.58082647 |
97 | diacylglycerol metabolic process (GO:0046339) | 3.58012999 |
98 | carnitine metabolic process (GO:0009437) | 3.57943804 |
99 | low-density lipoprotein particle remodeling (GO:0034374) | 3.54979940 |
100 | cholesterol homeostasis (GO:0042632) | 3.54644215 |
101 | serine family amino acid biosynthetic process (GO:0009070) | 3.54238966 |
102 | exogenous drug catabolic process (GO:0042738) | 3.52635067 |
103 | negative regulation of lipase activity (GO:0060192) | 3.52425621 |
104 | glucuronate metabolic process (GO:0019585) | 3.51208603 |
105 | uronic acid metabolic process (GO:0006063) | 3.51208603 |
106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50887116 |
107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50887116 |
108 | sterol homeostasis (GO:0055092) | 3.50372909 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.47882514 |
110 | fibrinolysis (GO:0042730) | 3.47756669 |
111 | ethanol metabolic process (GO:0006067) | 3.34605650 |
112 | low-density lipoprotein particle clearance (GO:0034383) | 3.34383164 |
113 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.32386825 |
114 | hormone catabolic process (GO:0042447) | 3.31372506 |
115 | intestinal cholesterol absorption (GO:0030299) | 3.22793875 |
116 | negative regulation of complement activation (GO:0045916) | 3.19993748 |
117 | protein-lipid complex assembly (GO:0065005) | 3.17267110 |
118 | lipoprotein metabolic process (GO:0042157) | 3.12614964 |
119 | fatty acid transmembrane transport (GO:1902001) | 3.10448554 |
120 | plasma lipoprotein particle organization (GO:0071827) | 3.09159373 |
121 | carnitine shuttle (GO:0006853) | 3.08919493 |
122 | NADH metabolic process (GO:0006734) | 3.05294402 |
123 | triglyceride catabolic process (GO:0019433) | 3.00609312 |
124 | alkaloid metabolic process (GO:0009820) | 2.97508544 |
125 | protein-lipid complex subunit organization (GO:0071825) | 2.93999323 |
126 | acute-phase response (GO:0006953) | 2.93894470 |
127 | regulation of sequestering of triglyceride (GO:0010889) | 2.92914698 |
128 | acylglycerol catabolic process (GO:0046464) | 2.89380411 |
129 | neutral lipid catabolic process (GO:0046461) | 2.89380411 |
130 | negative regulation of blood coagulation (GO:0030195) | 2.86763130 |
131 | negative regulation of hemostasis (GO:1900047) | 2.86763130 |
132 | protein activation cascade (GO:0072376) | 2.84563145 |
133 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.83470237 |
134 | fatty acid homeostasis (GO:0055089) | 2.81529734 |
135 | complement activation, classical pathway (GO:0006958) | 2.78090569 |
136 | heme transport (GO:0015886) | 2.76245470 |
137 | positive regulation of hemostasis (GO:1900048) | 2.75853043 |
138 | positive regulation of blood coagulation (GO:0030194) | 2.75853043 |
139 | macroautophagy (GO:0016236) | 2.75371595 |
140 | complement activation (GO:0006956) | 2.74229489 |
141 | drug transport (GO:0015893) | 2.71898393 |
142 | regulation of humoral immune response (GO:0002920) | 2.69343175 |
143 | phenylpropanoid metabolic process (GO:0009698) | 2.69167550 |
144 | carnitine transport (GO:0015879) | 2.68804770 |
145 | amino-acid betaine transport (GO:0015838) | 2.68804770 |
146 | blood coagulation, intrinsic pathway (GO:0007597) | 2.67580381 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.68072500 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.58794435 |
3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.07644864 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.87032312 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.63296940 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.89306142 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.18359179 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90750722 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24081928 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46284969 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00490711 |
12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6802356 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89811215 |
14 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77261162 |
15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68785777 |
16 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.67365503 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40805843 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38436556 |
19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37929321 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36727005 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35810171 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35571698 |
23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31023439 |
24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29819733 |
25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23621643 |
26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23512948 |
27 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23338206 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20210402 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17393031 |
30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14538353 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14300127 |
32 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11564937 |
33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10234591 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09963507 |
35 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09308155 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08939431 |
37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05871661 |
38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05370925 |
39 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.04966644 |
40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04420751 |
41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04078197 |
42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02155368 |
43 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00510281 |
44 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98725196 |
45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98481148 |
46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97939756 |
47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97450012 |
48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97428487 |
49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97054058 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96180532 |
51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93074849 |
52 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92071478 |
53 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91014995 |
54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90341646 |
55 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89918185 |
56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89346390 |
57 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89208305 |
58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89124374 |
59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89086067 |
60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88663453 |
61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88245745 |
62 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87734500 |
63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84976532 |
64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84856548 |
65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84856548 |
66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84671063 |
67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83601726 |
68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83310747 |
69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83257570 |
70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83113296 |
71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81373422 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80406010 |
73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79540941 |
74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79074689 |
75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79052413 |
76 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78969983 |
77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78206924 |
78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77412534 |
79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76724980 |
80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75721291 |
81 | RXR_22108803_ChIP-Seq_LS180_Human | 0.74260732 |
82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72733806 |
83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72320873 |
84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71889642 |
85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.71794423 |
86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71223731 |
87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.71106506 |
88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70458501 |
89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69501181 |
90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69008184 |
91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68470459 |
92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68089811 |
93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66629299 |
94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63197824 |
95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62028062 |
96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.61331781 |
97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60705682 |
98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.60207951 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59850397 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59734447 |
101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59678772 |
102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59447588 |
103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59034617 |
104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58370710 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58342773 |
106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57703900 |
107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56699613 |
108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56291301 |
109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55688978 |
110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55596643 |
111 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.54940742 |
112 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.54062167 |
113 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.54062167 |
114 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53586399 |
115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53349561 |
116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53336054 |
117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.53092618 |
118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52634458 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50799560 |
120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.49651078 |
121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.49327640 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.48832459 |
123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47978948 |
124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47876680 |
125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47645890 |
126 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.46813101 |
127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46577796 |
128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46568629 |
129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46458468 |
130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46202517 |
131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45685443 |
132 | AR_20517297_ChIP-Seq_VCAP_Human | 0.45622935 |
133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.45580834 |
134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44908834 |
135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43044221 |
136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42745523 |
137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.42731369 |
138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42609385 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.42601545 |
140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42597011 |
141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.42582033 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.99002733 |
2 | MP0005360_urolithiasis | 7.34694328 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.07162010 |
4 | MP0005365_abnormal_bile_salt | 5.94025727 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.91461559 |
6 | MP0003252_abnormal_bile_duct | 3.85706742 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.79700593 |
8 | MP0010329_abnormal_lipoprotein_level | 3.61730794 |
9 | MP0009840_abnormal_foam_cell | 3.00331684 |
10 | MP0003183_abnormal_peptide_metabolism | 2.98658769 |
11 | MP0005332_abnormal_amino_acid | 2.92791110 |
12 | MP0005083_abnormal_biliary_tract | 2.81460362 |
13 | MP0003195_calcinosis | 2.77117365 |
14 | MP0001666_abnormal_nutrient_absorption | 2.61805501 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.33792270 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.28144564 |
17 | * MP0002118_abnormal_lipid_homeostasis | 2.22714169 |
18 | * MP0000609_abnormal_liver_physiology | 2.09227481 |
19 | MP0002138_abnormal_hepatobiliary_system | 1.90919296 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82366320 |
21 | MP0003868_abnormal_feces_composition | 1.72032286 |
22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66420307 |
23 | MP0004264_abnormal_extraembryonic_tissu | 1.62154227 |
24 | MP0001764_abnormal_homeostasis | 1.53803066 |
25 | MP0005670_abnormal_white_adipose | 1.51273704 |
26 | MP0009643_abnormal_urine_homeostasis | 1.44911635 |
27 | MP0005451_abnormal_body_composition | 1.40880833 |
28 | MP0004130_abnormal_muscle_cell | 1.35210846 |
29 | MP0005409_darkened_coat_color | 1.35042966 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.25515963 |
31 | MP0003011_delayed_dark_adaptation | 1.23014351 |
32 | MP0003186_abnormal_redox_activity | 1.21642961 |
33 | MP0009697_abnormal_copulation | 1.20280120 |
34 | MP0000604_amyloidosis | 1.10583897 |
35 | MP0003656_abnormal_erythrocyte_physiolo | 1.07496041 |
36 | MP0010155_abnormal_intestine_physiology | 1.07133813 |
37 | MP0002254_reproductive_system_inflammat | 1.06663413 |
38 | * MP0000598_abnormal_liver_morphology | 1.05830613 |
39 | MP0002971_abnormal_brown_adipose | 1.04473980 |
40 | MP0005647_abnormal_sex_gland | 1.03873827 |
41 | MP0002876_abnormal_thyroid_physiology | 1.03143003 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.02960039 |
43 | MP0002837_dystrophic_cardiac_calcinosis | 1.01547343 |
44 | MP0010352_gastrointestinal_tract_polyps | 0.99274275 |
45 | MP0005666_abnormal_adipose_tissue | 0.97966631 |
46 | MP0009764_decreased_sensitivity_to | 0.97854337 |
47 | MP0005535_abnormal_body_temperature | 0.97009311 |
48 | MP0006036_abnormal_mitochondrial_physio | 0.95824318 |
49 | MP0002078_abnormal_glucose_homeostasis | 0.94197583 |
50 | MP0005164_abnormal_response_to | 0.93255174 |
51 | MP0003690_abnormal_glial_cell | 0.92769256 |
52 | MP0005334_abnormal_fat_pad | 0.90694599 |
53 | MP0003879_abnormal_hair_cell | 0.90565443 |
54 | MP0009785_altered_susceptibility_to | 0.90046068 |
55 | MP0002909_abnormal_adrenal_gland | 0.89803525 |
56 | MP0009763_increased_sensitivity_to | 0.89345858 |
57 | MP0001756_abnormal_urination | 0.87013938 |
58 | MP0010368_abnormal_lymphatic_system | 0.86623003 |
59 | * MP0009642_abnormal_blood_homeostasis | 0.86228034 |
60 | MP0003866_abnormal_defecation | 0.85203846 |
61 | MP0005084_abnormal_gallbladder_morpholo | 0.85128149 |
62 | MP0004883_abnormal_blood_vessel | 0.84746884 |
63 | MP0003329_amyloid_beta_deposits | 0.83329594 |
64 | MP0002132_abnormal_respiratory_system | 0.79286267 |
65 | MP0001661_extended_life_span | 0.77562549 |
66 | MP0004043_abnormal_pH_regulation | 0.77199026 |
67 | MP0008469_abnormal_protein_level | 0.76720359 |
68 | MP0000569_abnormal_digit_pigmentation | 0.75652758 |
69 | MP0005376_homeostasis/metabolism_phenot | 0.75056730 |
70 | MP0003303_peritoneal_inflammation | 0.74659966 |
71 | MP0003436_decreased_susceptibility_to | 0.73677739 |
72 | MP0003828_pulmonary_edema | 0.73649622 |
73 | MP0006138_congestive_heart_failure | 0.73196226 |
74 | MP0005448_abnormal_energy_balance | 0.71743064 |
75 | MP0002166_altered_tumor_susceptibility | 0.70648899 |
76 | MP0009765_abnormal_xenobiotic_induced | 0.68948980 |
77 | MP0000465_gastrointestinal_hemorrhage | 0.68179327 |
78 | MP0003045_fibrosis | 0.68031757 |
79 | MP0001664_abnormal_digestion | 0.66595898 |
80 | MP0005266_abnormal_metabolism | 0.66145447 |
81 | MP0002822_catalepsy | 0.65975671 |
82 | MP0002136_abnormal_kidney_physiology | 0.62920564 |
83 | MP0004484_altered_response_of | 0.62855808 |
84 | MP0010678_abnormal_skin_adnexa | 0.62293565 |
85 | MP0005220_abnormal_exocrine_pancreas | 0.62215605 |
86 | MP0001845_abnormal_inflammatory_respons | 0.61612835 |
87 | MP0006035_abnormal_mitochondrial_morpho | 0.61280980 |
88 | MP0005408_hypopigmentation | 0.60872722 |
89 | MP0002419_abnormal_innate_immunity | 0.60318926 |
90 | MP0001533_abnormal_skeleton_physiology | 0.59245465 |
91 | MP0000003_abnormal_adipose_tissue | 0.57807974 |
92 | MP0000230_abnormal_systemic_arterial | 0.55546963 |
93 | MP0009115_abnormal_fat_cell | 0.54442552 |
94 | MP0005025_abnormal_response_to | 0.54299667 |
95 | MP0003453_abnormal_keratinocyte_physiol | 0.53479706 |
96 | MP0003953_abnormal_hormone_level | 0.53092309 |
97 | MP0000371_diluted_coat_color | 0.52695902 |
98 | MP0004147_increased_porphyrin_level | 0.51625771 |
99 | MP0005375_adipose_tissue_phenotype | 0.51063217 |
100 | MP0004185_abnormal_adipocyte_glucose | 0.50552438 |
101 | MP0008874_decreased_physiological_sensi | 0.50368370 |
102 | MP0003075_altered_response_to | 0.50219898 |
103 | MP0000639_abnormal_adrenal_gland | 0.49147839 |
104 | MP0001765_abnormal_ion_homeostasis | 0.47726024 |
105 | MP0003638_abnormal_response/metabolism_ | 0.47486610 |
106 | MP0010234_abnormal_vibrissa_follicle | 0.47011930 |
107 | MP0002928_abnormal_bile_duct | 0.46324461 |
108 | MP0002796_impaired_skin_barrier | 0.45659662 |
109 | MP0002970_abnormal_white_adipose | 0.45306942 |
110 | MP0002168_other_aberrant_phenotype | 0.43561412 |
111 | MP0005167_abnormal_blood-brain_barrier | 0.43514274 |
112 | MP0005058_abnormal_lysosome_morphology | 0.43460065 |
113 | MP0003724_increased_susceptibility_to | 0.43406212 |
114 | MP0009384_cardiac_valve_regurgitation | 0.43325855 |
115 | MP0008872_abnormal_physiological_respon | 0.41312852 |
116 | MP0005395_other_phenotype | 0.40517143 |
117 | MP0005166_decreased_susceptibility_to | 0.40462654 |
118 | MP0009053_abnormal_anal_canal | 0.37704688 |
119 | MP0003959_abnormal_lean_body | 0.36306911 |
120 | MP0005464_abnormal_platelet_physiology | 0.35410411 |
121 | MP0002090_abnormal_vision | 0.35398997 |
122 | MP0009780_abnormal_chondrocyte_physiolo | 0.35247838 |
123 | MP0003300_gastrointestinal_ulcer | 0.35026044 |
124 | MP0008873_increased_physiological_sensi | 0.34932373 |
125 | MP0008961_abnormal_basal_metabolism | 0.34031604 |
126 | MP0005248_abnormal_Harderian_gland | 0.33356759 |
127 | MP0001881_abnormal_mammary_gland | 0.33155900 |
128 | MP0005330_cardiomyopathy | 0.32789504 |
129 | MP0004782_abnormal_surfactant_physiolog | 0.31997002 |
130 | MP0000249_abnormal_blood_vessel | 0.30933812 |
131 | MP0009672_abnormal_birth_weight | 0.29824906 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.69623489 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.61524273 |
3 | Deep venous thrombosis (HP:0002625) | 6.54475375 |
4 | Xanthomatosis (HP:0000991) | 6.07086659 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.95575710 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.72722600 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.57998387 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.17819641 |
9 | Complement deficiency (HP:0004431) | 4.86319315 |
10 | Hyperammonemia (HP:0001987) | 4.67830132 |
11 | Ketosis (HP:0001946) | 4.54001086 |
12 | Hyperglycinuria (HP:0003108) | 4.53123163 |
13 | Epidermoid cyst (HP:0200040) | 4.47602696 |
14 | Hypolipoproteinemia (HP:0010981) | 4.47190742 |
15 | Hyperglycinemia (HP:0002154) | 4.44142572 |
16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.39514724 |
17 | Abnormality of glycine metabolism (HP:0010895) | 4.35321488 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.35321488 |
19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12916781 |
20 | Hypoglycemic coma (HP:0001325) | 4.11456575 |
21 | Joint hemorrhage (HP:0005261) | 4.08969006 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.07553816 |
23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.99900988 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96016304 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93417038 |
26 | Fat malabsorption (HP:0002630) | 3.76600699 |
27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.75228007 |
28 | Abnormality of methionine metabolism (HP:0010901) | 3.68522247 |
29 | Ketoacidosis (HP:0001993) | 3.62429489 |
30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56211901 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48544152 |
32 | Abnormality of complement system (HP:0005339) | 3.46973103 |
33 | Hypercholesterolemia (HP:0003124) | 3.43851755 |
34 | Eczematoid dermatitis (HP:0000976) | 3.39413163 |
35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36156751 |
36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33706725 |
37 | Hyperbilirubinemia (HP:0002904) | 3.11276680 |
38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.08724905 |
39 | Delayed CNS myelination (HP:0002188) | 3.08095797 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04898339 |
41 | Abnormality of purine metabolism (HP:0004352) | 3.02985056 |
42 | Gout (HP:0001997) | 3.02697055 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 2.98514484 |
44 | Metabolic acidosis (HP:0001942) | 2.90805411 |
45 | Skin nodule (HP:0200036) | 2.89667522 |
46 | Nephritis (HP:0000123) | 2.88589205 |
47 | Dicarboxylic aciduria (HP:0003215) | 2.85657969 |
48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85657969 |
49 | Myocardial infarction (HP:0001658) | 2.84278615 |
50 | Right ventricular cardiomyopathy (HP:0011663) | 2.83141518 |
51 | Hepatocellular carcinoma (HP:0001402) | 2.77382701 |
52 | Spontaneous abortion (HP:0005268) | 2.72009043 |
53 | Steatorrhea (HP:0002570) | 2.70129580 |
54 | Lethargy (HP:0001254) | 2.65567732 |
55 | Vascular calcification (HP:0004934) | 2.58802431 |
56 | Hypoglycemic seizures (HP:0002173) | 2.56452463 |
57 | Facial shape deformation (HP:0011334) | 2.54593523 |
58 | Potter facies (HP:0002009) | 2.54593523 |
59 | Orchitis (HP:0100796) | 2.48811798 |
60 | Systemic lupus erythematosus (HP:0002725) | 2.46336873 |
61 | Generalized aminoaciduria (HP:0002909) | 2.43401267 |
62 | Acanthocytosis (HP:0001927) | 2.42561200 |
63 | Abnormal gallbladder morphology (HP:0012437) | 2.41970583 |
64 | Malnutrition (HP:0004395) | 2.40731441 |
65 | Pigmentary retinal degeneration (HP:0001146) | 2.40465160 |
66 | Abnormality of proline metabolism (HP:0010907) | 2.40071241 |
67 | Hydroxyprolinuria (HP:0003080) | 2.40071241 |
68 | Spastic diplegia (HP:0001264) | 2.38943574 |
69 | Cholelithiasis (HP:0001081) | 2.38295601 |
70 | Sensorimotor neuropathy (HP:0007141) | 2.37413266 |
71 | Cerebral edema (HP:0002181) | 2.36603633 |
72 | Widely patent fontanelles and sutures (HP:0004492) | 2.35469612 |
73 | Cardiovascular calcification (HP:0011915) | 2.32303778 |
74 | Abnormality of vitamin metabolism (HP:0100508) | 2.31163254 |
75 | Neonatal onset (HP:0003623) | 2.31033756 |
76 | Mitral stenosis (HP:0001718) | 2.28954525 |
77 | Cholecystitis (HP:0001082) | 2.28088129 |
78 | Abnormal gallbladder physiology (HP:0012438) | 2.28088129 |
79 | Hypochromic microcytic anemia (HP:0004840) | 2.27667711 |
80 | Vomiting (HP:0002013) | 2.24669002 |
81 | Late onset (HP:0003584) | 2.23948878 |
82 | Amyloidosis (HP:0011034) | 2.22608082 |
83 | Pancreatitis (HP:0001733) | 2.20401049 |
84 | Proximal tubulopathy (HP:0000114) | 2.20036205 |
85 | Hyperuricemia (HP:0002149) | 2.17708715 |
86 | Increased purine levels (HP:0004368) | 2.17708715 |
87 | Flat acetabular roof (HP:0003180) | 2.17448041 |
88 | Optic neuritis (HP:0100653) | 2.16600501 |
89 | Retrobulbar optic neuritis (HP:0100654) | 2.16600501 |
90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15635834 |
91 | Brushfield spots (HP:0001088) | 2.14710032 |
92 | * Irritability (HP:0000737) | 2.14357058 |
93 | Alkalosis (HP:0001948) | 2.12546794 |
94 | Esophageal varix (HP:0002040) | 2.09939766 |
95 | Gingivitis (HP:0000230) | 2.08802246 |
96 | Glomerulonephritis (HP:0000099) | 2.07844298 |
97 | Hemorrhage of the eye (HP:0011885) | 2.07599508 |
98 | Enlarged kidneys (HP:0000105) | 2.06723930 |
99 | Rickets (HP:0002748) | 2.02224548 |
100 | Osteomalacia (HP:0002749) | 2.00001436 |
101 | Abnormal cartilage morphology (HP:0002763) | 1.99290810 |
102 | Glycosuria (HP:0003076) | 1.96154136 |
103 | Abnormality of urine glucose concentration (HP:0011016) | 1.96154136 |
104 | Abnormality of the gallbladder (HP:0005264) | 1.96022050 |
105 | Fair hair (HP:0002286) | 1.95079913 |
106 | Myositis (HP:0100614) | 1.93358959 |
107 | Hyperglycemia (HP:0003074) | 1.85943268 |
108 | Hypertriglyceridemia (HP:0002155) | 1.85514101 |
109 | Renal cortical cysts (HP:0000803) | 1.84276391 |
110 | Peritonitis (HP:0002586) | 1.84196410 |
111 | Thrombophlebitis (HP:0004418) | 1.83473919 |
112 | Myoglobinuria (HP:0002913) | 1.83248954 |
113 | Gingival bleeding (HP:0000225) | 1.83235651 |
114 | Opisthotonus (HP:0002179) | 1.83227185 |
115 | Pulmonary embolism (HP:0002204) | 1.83026929 |
116 | Papillary thyroid carcinoma (HP:0002895) | 1.82080698 |
117 | Poikilocytosis (HP:0004447) | 1.80600106 |
118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79558855 |
119 | Menorrhagia (HP:0000132) | 1.79474787 |
120 | Gastrointestinal infarctions (HP:0005244) | 1.78624234 |
121 | Status epilepticus (HP:0002133) | 1.78474777 |
122 | Hyperactive renin-angiotensin system (HP:0000841) | 1.78152740 |
123 | Mucopolysacchariduria (HP:0008155) | 1.76704652 |
124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76704652 |
125 | Chronic diarrhea (HP:0002028) | 1.76242509 |
126 | Hypophosphatemia (HP:0002148) | 1.75704807 |
127 | Vacuolated lymphocytes (HP:0001922) | 1.70791149 |
128 | Abdominal distention (HP:0003270) | 1.70419247 |
129 | Abnormality of macrophages (HP:0004311) | 1.68880501 |
130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68498212 |
131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68498212 |
132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68498212 |
133 | Renal tubular acidosis (HP:0001947) | 1.68364344 |
134 | Keratoconjunctivitis sicca (HP:0001097) | 1.65920465 |
135 | Decreased circulating renin level (HP:0003351) | 1.65844195 |
136 | Abnormal tarsal ossification (HP:0008369) | 1.65365379 |
137 | Nausea (HP:0002018) | 1.63879464 |
138 | Hypophosphatemic rickets (HP:0004912) | 1.63019397 |
139 | Purpura (HP:0000979) | 1.62057965 |
140 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.60636910 |
141 | Abnormality of glycolipid metabolism (HP:0010969) | 1.60636910 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.30145043 |
2 | SIK1 | 4.22369659 |
3 | ERN1 | 3.75927842 |
4 | FGFR4 | 3.66459430 |
5 | ACVR1B | 3.10693013 |
6 | INSRR | 2.84021243 |
7 | TRIB3 | 2.63975406 |
8 | ERBB4 | 2.49865068 |
9 | MST1R | 2.24563125 |
10 | PKN2 | 2.22480269 |
11 | TAOK3 | 2.19310528 |
12 | MAP2K4 | 2.16514616 |
13 | STK39 | 2.07648428 |
14 | AKT3 | 1.80966267 |
15 | FRK | 1.72780086 |
16 | BLK | 1.70173014 |
17 | DAPK2 | 1.58594945 |
18 | MAPK11 | 1.57274657 |
19 | LATS1 | 1.50161725 |
20 | CAMKK2 | 1.47538949 |
21 | NLK | 1.47484119 |
22 | EPHA2 | 1.47070003 |
23 | PTK6 | 1.44756935 |
24 | CAMK1D | 1.44397431 |
25 | FGFR2 | 1.43817080 |
26 | PIK3CG | 1.41609482 |
27 | MAP3K7 | 1.37524216 |
28 | PINK1 | 1.37048901 |
29 | PRKAA2 | 1.36718764 |
30 | MAP3K12 | 1.35525617 |
31 | FLT3 | 1.33654005 |
32 | TAOK1 | 1.29790192 |
33 | PDK3 | 1.29524824 |
34 | PDK4 | 1.29524824 |
35 | RIPK1 | 1.23789228 |
36 | YES1 | 1.23771248 |
37 | WNK4 | 1.17865467 |
38 | ABL2 | 1.17776732 |
39 | JAK2 | 1.12357709 |
40 | NEK9 | 1.10381626 |
41 | MAP3K6 | 1.08719703 |
42 | PRKG2 | 1.03056865 |
43 | TYK2 | 1.02490544 |
44 | CAMK1G | 1.00788836 |
45 | EPHB1 | 0.99492757 |
46 | TIE1 | 0.99382582 |
47 | MAPKAPK3 | 0.98806478 |
48 | OBSCN | 0.97788216 |
49 | JAK1 | 0.96570780 |
50 | ZAP70 | 0.96170620 |
51 | SGK3 | 0.95625625 |
52 | EPHA4 | 0.94212374 |
53 | STK24 | 0.90335959 |
54 | PRKAA1 | 0.90066130 |
55 | ERBB2 | 0.89697812 |
56 | TRPM7 | 0.88252686 |
57 | MET | 0.87833646 |
58 | KDR | 0.85683780 |
59 | PDPK1 | 0.85596447 |
60 | LMTK2 | 0.85282882 |
61 | STK38L | 0.85087346 |
62 | PRKCZ | 0.84091964 |
63 | IRAK1 | 0.83420460 |
64 | MAP2K3 | 0.80680481 |
65 | OXSR1 | 0.80678451 |
66 | MAPK12 | 0.80195698 |
67 | PRKACG | 0.78888782 |
68 | MAP3K5 | 0.78167410 |
69 | SGK494 | 0.78155669 |
70 | SGK223 | 0.78155669 |
71 | WNK3 | 0.75788914 |
72 | RIPK4 | 0.73639562 |
73 | PDK2 | 0.73449098 |
74 | MAPK4 | 0.71919635 |
75 | GRK6 | 0.71665727 |
76 | GSK3A | 0.71203483 |
77 | WNK1 | 0.71147180 |
78 | SGK2 | 0.70861146 |
79 | RET | 0.69145243 |
80 | CAMK2G | 0.68365052 |
81 | SCYL2 | 0.67489398 |
82 | TBK1 | 0.67113414 |
83 | MAP3K3 | 0.66631249 |
84 | MAPK15 | 0.66004199 |
85 | FGFR3 | 0.65664849 |
86 | EEF2K | 0.63811355 |
87 | PTK2 | 0.63603231 |
88 | PIK3CA | 0.61114962 |
89 | MAP3K2 | 0.61082864 |
90 | TGFBR2 | 0.60885898 |
91 | EPHA3 | 0.60665933 |
92 | PDK1 | 0.60472778 |
93 | MAP2K1 | 0.60158708 |
94 | PDGFRB | 0.59825467 |
95 | PAK3 | 0.58777132 |
96 | HCK | 0.57263849 |
97 | CDK6 | 0.57062852 |
98 | MAP3K10 | 0.56876893 |
99 | PDGFRA | 0.55815302 |
100 | PHKG2 | 0.55362057 |
101 | PHKG1 | 0.55362057 |
102 | FGR | 0.55072190 |
103 | MYLK | 0.55009704 |
104 | KSR2 | 0.54986009 |
105 | DYRK1B | 0.54897005 |
106 | MAP2K6 | 0.54599869 |
107 | PRPF4B | 0.52840902 |
108 | RPS6KB1 | 0.52066386 |
109 | MARK2 | 0.50435364 |
110 | STK38 | 0.49480294 |
111 | CSK | 0.48795938 |
112 | IRAK4 | 0.48216402 |
113 | MATK | 0.47812565 |
114 | ICK | 0.47377593 |
115 | STK11 | 0.46734612 |
116 | MAP3K13 | 0.46432248 |
117 | NEK6 | 0.45749785 |
118 | FER | 0.44686170 |
119 | SGK1 | 0.43061828 |
120 | NTRK3 | 0.42938671 |
121 | IGF1R | 0.42493191 |
122 | DDR2 | 0.41603865 |
123 | PRKCH | 0.41207889 |
124 | NEK1 | 0.40737318 |
125 | MAP3K14 | 0.40706993 |
126 | PKN1 | 0.39746428 |
127 | MAPK7 | 0.39566987 |
128 | IRAK3 | 0.39109556 |
129 | PRKCQ | 0.38608405 |
130 | MAP3K1 | 0.37525529 |
131 | NTRK1 | 0.37283261 |
132 | LATS2 | 0.37237702 |
133 | CAMKK1 | 0.37057856 |
134 | MTOR | 0.35485101 |
135 | MAP3K11 | 0.34364081 |
136 | MAP3K4 | 0.33041271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12546001 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60974273 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21038083 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19674918 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90138514 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68674327 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68396603 |
8 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.67896214 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66743578 |
10 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50944764 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42443425 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39548535 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35021472 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33421312 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18079626 |
16 | * Peroxisome_Homo sapiens_hsa04146 | 2.10877354 |
17 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07946019 |
18 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03289565 |
19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95859029 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83963684 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82957768 |
22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81134070 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79525739 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74565979 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71789123 |
26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66154066 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64950466 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62667068 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60230394 |
30 | Bile secretion_Homo sapiens_hsa04976 | 1.58856015 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55402825 |
32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51878778 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50076294 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49508424 |
35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47841127 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43680040 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41848784 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37082299 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34537282 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33899672 |
41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29888966 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26945899 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25481652 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22811274 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.20628201 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16207429 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15069339 |
48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08952750 |
49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05428916 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03255180 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01205594 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98482356 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93817562 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92608864 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91879934 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90351072 |
57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88279112 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.87362059 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83904093 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79051222 |
61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77564432 |
62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76892031 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76084040 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67146081 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63544729 |
66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54615663 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50975916 |
68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45258063 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.44230573 |
70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44007537 |
71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43008896 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42527372 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41425829 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.37602052 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34351226 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33393305 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31925571 |
78 | Renin secretion_Homo sapiens_hsa04924 | 0.29271929 |
79 | Prion diseases_Homo sapiens_hsa05020 | 0.28010352 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23943602 |
81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23502302 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19826652 |
83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19507863 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.19066935 |
85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18781976 |
86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18414458 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.18284927 |
88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.17134142 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15137730 |
90 | Tuberculosis_Homo sapiens_hsa05152 | 0.14203572 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.13341745 |
92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12920641 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12806159 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12410883 |
95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11966307 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11782596 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03727260 |
98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01605801 |
99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1792606 |
100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1746506 |
101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1729732 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1685369 |
103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1660562 |
104 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1580171 |
105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1345625 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1286487 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1235085 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1217479 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1090380 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1047676 |
111 | Mineral absorption_Homo sapiens_hsa04978 | -0.1017347 |
112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0863052 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0809785 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0620250 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0569473 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0308643 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0277984 |
118 | * alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0227455 |